Cancer Horizons27 Loka 2022

S5 Ep7: Reading the Fine Print: How a Footnote on a CT Scan Led to an Unexpected Lung Cancer Diagnosis

Has anyone ever thought that reading the fine print of a document would save their life?
When David Sturges, an attorney from New Ulm, Minnesota, went to the doctor for a CT scan to assess his risk for heart disease, he wasn’t expecting a lung cancer diagnosis. After all, he had quit smoking almost 20 years ago and was only 53 years old.
However, when the scan came back with a footnote noting there was a mass on the lobe of his right lung, Sturges immediately went in for a biopsy. In February 2002, he was diagnosed with stage 1A non-small lung cancer and shortly after, had a lobectomy (the removal of the lower lobe of the right lung).

A year later, his doctor noticed a new suspicious mass and recommended another surgery. When Sturges sought a second opinion, the new oncologist stated that he did not recommend surgery at that time. With regular screening that monitored the growth of the tumor, Sturges was able to avoid another surgery until 2017.

On today’s episode of the “Cancer Horizons” podcast, Sturges, who is now 75, shares how cancer treatments have changed in the past 21 years, his advocacy work with the Lung Cancer Foundation of America (a research foundation based in New Ulm, Minnesota), the importance of seeking genetic testing, decreasing the stigma around smokers getting lung cancer and more.
For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.

Tämä jakso on lisätty Podme-palveluun avoimen RSS-syötteen kautta eikä se ole Podmen omaa tuotantoa. Siksi jakso saattaa sisältää mainontaa.

Jaksot(295)

S7 Ep2: Breaking Down Metastatic Triple-Negative Breast Cancer Treatments

CURE sat down with Dr. Natalie S. Berger for the latest episode of the “Cancer Horizons” podcast to discuss frontline treatment options for patients with metastatic triple-negative breast cancer. Berg...

31 Joulu 202514min

S7 Ep1: The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.

18 Maalis 202510min

S6 Ep23: ROS1+ Non-Small Cell Lung Cancer: Progress in Care

17 Syys 202419min

S6 Ep22: Oncology Approvals, Psychological Outcomes for Survivors and an Ovarian Cancer Vaccine

Last week we saw some FDA approvals come through, as well as research that explored the psychosocial outcomes of individuals who survived pediatric rhabdosarcoma. And finally, we’ll discuss another ca...

4 Maalis 20247min

S6 Ep21: Cannabis Talks During Cancer, Cardiometabolic Comorbidities and Current Research

In addition to a breakthrough therapy designation for a lung cancer drug, this week we’ll be talking a lot about additional side effects and health conditions that may come with a cancer diagnosis, an...

4 Maalis 202410min

S6 Ep20: FDA Approvals from February 2024

Last week, the Food and Drug Administration (FDA) approved four different therapies in the oncology space — one of which, Amtagvi, marks the first cellular therapy for the treatment of solid cancers. ...

23 Helmi 20246min

S6 Ep19: Pancreatic Cancer Approval, Expert Discussion on Cancer Vaccine Development

Last week, we saw some FDA approvals for a new drug regimens, as well as some expert opinion about cancer vaccines. Additionally research touched upon the potential benefit of concurrent ctDNA and tum...

19 Helmi 20249min

S6 Ep18: Guidelines for Childhood Neuroblastoma, FDA Decisions and More

Last week, we saw a few moving parts in the regulatory space, from new NCCN guidelines for pediatric neuroblastoma treatment to FDA Fast Tracks and Priority Reviews. Also last week, we covered researc...

12 Helmi 20247min